insulin glulisine
| Form | Strength |
|---|---|
| SOLUTION, SUBCUTANEOUS | 100 units/mL |
| Refrigerated Products Stored At Room Temperature (RT) | |
|---|---|
| Medication | Allowable time at room temp |
| insulins | 28 days |
| Adapted from Extended Stability for Parenteral Drugs, 7th Edition; 2023 & Lexi-Drugs. UpToDate LexiDrug. UpToDate Inc. https://online.lexi.com. Accessed September 2025. | |
| Per policy, these hazardous drugs have special waste requirements. | |
|---|---|
| Generic (Brand) | Waste Requirements |
| insulin glulisine (Apidra) | Contains M-Cresol ⇒ BLACK BUCKET |
| 2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults. | |
|---|---|
| Medication: | insulin glulisine (Apidra) |
| Criteria 1: Potentially inappropriate medication use in older adults. (Table 2) | |
| Drug(s) | insulin, sliding scale (insulin regimens containing only short- or rapid-acting insulin dosed according to current blood glucose levels without concurrent use of basal or long-acting insulin) |
| Rationale | Higher risk of hypoglycemia without improvement in hyperglycemia management regardless of care setting. Avoid insulin regimens that include only short- or rapid-acting insulin dosed according to current blood glucose levels without concurrent use of basal or long-acting insulin. This recommendation does not apply to regimens that contain basal insulin or long-acting insulin. |
| Recommendation | Avoid |
| Quality of evidence: Moderate, Strength of Recommendation: Strong | |